Home » Topics » Regulatory » Patents

Patents
RSS

Dual PDE4 inhibitors and mAChR agonists in early development at GSK

Sep. 22, 2009

Casein kinase II inhibitors described by Bristol-Myers Squibb as oncolytics

Sep. 22, 2009

Novel compounds claimed by The Salk Institute for acute neural injury therapy

Sep. 22, 2009

New compounds for asthma therapy claimed by AstraZeneca and Argenta Discovery

Sep. 21, 2009

Neurogen describes novel TRPV1 modulators for the treatment of pain

Sep. 21, 2009

OSI dislcoses novel protein kinase inhibitors for treating cancer

Sep. 21, 2009

Novel MEK inhibitors in early development at UCB

Sep. 21, 2009

Merz discloses mGluR5 modulators for the treatment of pain

Sep. 18, 2009

Xinchang Pharmaceutical Factory claims novel anticancer compounds

Sep. 18, 2009

Apoptosis inducers in early development at Chinese Academy of Medical Science

Sep. 18, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...